GW583340

Overview

GW583340 is an orally active ErbB-2 / EGFR tyrosine kinase inhibitor. GW583340 exhibits antitumor activity in xenograft models with EGFR overexpression or ErbB-2 overexpression. GW583340 is applicable to research related to head and neck cancer , breast cancer , and gastric cancer .

Application

Products | Products > Disease Areas > Gastric Cancer | Products > Disease Areas > Digestive System Cancer | Products > Disease Areas > Cancer | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Breast Cancer | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Signaling Pathways > JAK/STAT Signaling | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Tyrosine Hydroxylase | Products > Signaling Pathways > EGFR

Product Information

• Catalog No.: HY-103439A
• CAS No.: 388082-81-3
• Molecular Formula: C28H25ClFN5O3S2
• Molecular Weight: 598.11
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source